The influence of acetaldehyde and glycosaminoglycans upon factor Xa- and factor X-deficient plasma

Canadian Journal of Physiology and Pharmacology

Volumn 80, Issue 9, 2002, Pages 879-886

  Brecher, Arthur S ^a   Hommema, Eric L ^a  

^a BOWLING GREEN STATE UNIVERSITY   (United States)

Author keywords

Acetaldehyde; Blood coagulation; Factor Xa; Glycosaminoglycans; Heparin

Indexed keywords

ACETALDEHYDE; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; CALCIUM ION; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARIN;

ALCOHOLISM; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD LEVEL; HUMAN; PARTIAL THROMBOPLASTIN TIME; PLASMA; PRIORITY JOURNAL;

ACETALDEHYDE; BLOOD COAGULATION; FACTOR X; FACTOR X DEFICIENCY; FACTOR XA; GLYCOSAMINOGLYCANS; HUMANS;

EID: 0036442995     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y02-111     Document Type: Article

References (29)

1. Basista, M.H., Joseph, A., Smolen, S., Koterba, A., and Brecher, A.S. 1994. Acetaldehyde alters coagulation function. Dig. Dis. Sci. 39: 2421-2425.
2. Bauer, K.A., and Rosenberg, R.D. 1995. Control of coagulation reactions. In Williams; Hematology. 5th Ed. Edited by E. Beutler, M.A. Lichtman, B.S. Coller, and T.J. Kipps. McGraw-Hill, New York, N.Y. pp. 1239-1252.
3. Bordalo, O., Batista, A., Geraldes, J., Neto, F., Mascarenhas, F., Leitao, N., Noronha, M., Lamry, J., and Silva, P.E. 1974. Clinical correlations in alcoholic patients without manifest cirrhosis. Am. J. Gastroenterol. 61: 371-378.
4. Brecher, A.S. 1998. Clotting system. In Encyclopedia of Immunology. 2nd Ed. Edited by P.J. Delves and I. Roitt. Academic Press, Ltd., London. pp. 578-586.
5. Brecher, A.S., and Adamu, M.T. 2001. Enhancement of the anticoagulant effect of acetaldehyde by sulfated glycosaminoglycans. Dig. Dis. Sci. 46: 2033-2042.
6. Brecher, A.S., and Fu, Q. 1999. Coagulation protein function: The influence of acetaldehyde-modified heparin on thrombin activity. J. Invest. Med. 47: 76-80.
7. Brecher, A.S., Hellman, K., Dulin, C., and Basista, M.H. 1996a. Diminution of antithrombin III function by acetaldehyde. Dig. Dis. Sci. 43: 1746-1751.
8. Brecher, A.S., Koterba, A.P., and Basista, M.H. 1996b. Coagulation protein function. III. Effect of acetaldehyde upon the activation of prothrombin. Alcohol, 13: 423-429.
9. Brecher, A.S., Koterba, A.P., and Basista, M.H. 1996c. Coagulation protein function. IV. Effect of acetaldehyde upon factor X and factor Xa, the proteins at the gateway to the common coagulation pathway. Alcohol, 13: 539-545.
10. Brecher, A.S., Hellman, K., and Basista, M.H. 1997. A persepective on acetaldehyde concentrations and toxicity in man and animals. Alcohol, 14: 493-496.
11. Brecher, A.S., Hellman, K., and Basista, M.H. 1998. Coagulation protein function VI: Augmentation of anticoagulant function by acetaldehyde-treated heparin. Dig. Dis. Sci. 44: 1349-1355.
12. Caron, J.P., Kaneene, J.B., and Miller, R. 1996. Results of a survey of equine practitioners on the use and perceived efficacy of polysulfated glycosaminoglycans. J. Am. Vet. Med. Assn. 209: 1564-1568.
13. Condorelli, M., Chiariello, M., Dagianti, A., Penco, M., Dalla Volta, S., Pengo, V., Schivazappa, L., Mattioli, G., Mattioli, A.V., Brusoni, B., Trotta, E., and Bignamini, A. 1994. IPO-V2: A prospective, multicenter, randomized comparative clinical investigation of the effects of sulodexide in preventing cardiovascular accidents in the first year after acute myocardial infarction. J. Am. Coll. Cardiol. 23: 27-34.
14. Crabb, D.W., and Lumeng, L. 1989. Alcoholic liver diseases. In Textbook of internal medicine. Edited by W.N. Kelly. Lippencott, Philadelphia, Pa. pp. 592-602.
15. Greenberg, C.S., and Orthner, C.L. 1999. Blood coagulation and fibrinolysis. In Wintrobe's Hematology. 10th Ed. Edited by G.R. Lee, J. Lukens, F. Paraskaevas, J.P. Greer, and G.M. Rodgers. Williams & Wilkins, Baltimore, Md. pp. 684-764.
16. Kozma, E.M., Olczyk, K., Glowacki, A., Kosmosinska, K., Sonecki, P., Najmiec, T., and Jazwiec, M. 1996. Glycosaminoglycans of human serum and their alterations in diabetes mellitus. Acta Biochim. Pol. 43: 567-574.
17. Kumari, K.T., Augustine, J., Leelamma, S., Kurup, P.A., Ravikumar, A., Sajeesh, K., Nair, A.R., Vijayalekshmi, N., Karthikeyan, S. 1995. Elevated serum glycosaminoglycans with hypomagnesemia in patients with coronary artery disease & thrombotic stroke. Indian J. Med. Sci. 101: 115-119.
18. Lelbach, W.K. 1976. Epidemiology of alcoholic liver disease. In Progress in Liver Diseases Edited by H. Popper and F. Schaffner. Grune and Stratton. New York. pp. 494-515.
19. Olson, S.T., and Bjork, I. 1992. Regulation of thrombin by antithrombin and heparin cofactor II. In Thrombin Structure and Function. Edited by L.J. Berliner. Plenum Press, New York. pp. 159-217.
20. Parker, K.A., and Tollefsen, D.M. 1985. The protease specificity of heparin cofactor II. J. Biol. Chem. 260: 3501-3505.
21. Pavelka, K., Jr., Sedlackova, M., Gatterova, J., Becvar, R., and Pavelka, K., Sr. 1995. Glycosaminoglycan polysulfuric acid (GAGPS) in osteoarthritis of the knee. Osteoarthritis and Cartilage, 3: 15-23.
22. Podolsky, D.K., and Isselbacher, K.J. 1994. Cirrhosis. In Harrison's Principles of Internal Medicine. 13th Ed. Edited by K.J. Isselbacher, E. Braunwald, J.D. Wilson, J.B. Martin, A.S. Fauci, and D.L. Kasper. McGraw-Hill, Inc. New York. pp. 1483-1495.
23. Ramamurthi, R., Leevy, C.B., and Reddi, A.S. 1990. Effect of alcohol on urinary glycosaminoglycan and protein excretion in normal and diabetic mice. Alcohol & Alcoholism, 25: 45-50.
24. Rascob, G., Hull, R.D., and Pineo, G.F. 2001 Heparin, hirudin, and related agents. In Williams Hematology. 6th Ed. Edited by E. Beutler, M.A. Lichtman, B.S. Coller, T.J. Kipps, and U. Seligsohn. McGraw-Hill, Inc. New York. pp. 1793-1801.
25. Rosenberg, R.D. 1985. The role of heparin and heparin-like molecules in thrombosis and atherosclerosis. Fed. Proc. 44: 404-409.
26. Sabol, D.A., Basista, M.H., Brecher, A.S., Haider, K., and Kleshinski, J. 1999. Coagulation protein function VII Diametric effects of acetaldehyde on factor VII and factor IX function. Dig. Dis. Sci. 44: 2564-2567.
27. Silverstein, R.L. 1995. Drugs affecting hemostasis. In Principles of Pharmacology. P.L. Munson, Editor-in-chief. Chapman and Hall. New York, NY. pp. 1123-1143.
28. Tollefsen, D.M., Pestka, C.A., and Monafo, W.J. 1983. Activation of heparin cofactor II by dermatan sulfate. J. Biol. Chem. 258: 6713-6716.
29. th Ed. Merck and Co., Inc. Rahway, N.J.